Insider Transactions in Q4 2020 at Eidos Therapeutics, Inc. (EIDX)
Insider Transaction List (Q4 2020)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 28
2020
|
Jonathan C Fox Officer |
SELL
Bona fide gift
|
Direct |
500
-0.13%
|
-
|
Dec 15
2020
|
Cameron Turtle Chief Business Officer |
SELL
Open market or private sale
|
Direct |
26,294
-9.8%
|
$2,918,634
$111.69 P/Share
|
Dec 15
2020
|
Cameron Turtle Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,294
+14.8%
|
$394,410
$15.1 P/Share
|
Dec 02
2020
|
Uma Sinha Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.39%
|
$455,000
$91.28 P/Share
|
Nov 11
2020
|
Cameron Turtle Chief Business Officer |
SELL
Bona fide gift
|
Direct |
1,500
-2.88%
|
-
|
Nov 11
2020
|
Cameron Turtle Chief Business Officer |
SELL
Open market or private sale
|
Direct |
13,410
-7.16%
|
$992,340
$74.51 P/Share
|
Nov 09
2020
|
Franco Valle Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
1,623
-100.0%
|
$120,102
$74.93 P/Share
|
Nov 09
2020
|
Franco Valle Senior Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
1,623
+50.0%
|
$11,361
$7.24 P/Share
|
Nov 02
2020
|
Cameron Turtle Chief Business Officer |
SELL
Open market or private sale
|
Direct |
12,500
-5.53%
|
$887,500
$71.32 P/Share
|
Nov 02
2020
|
Cameron Turtle Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+4.66%
|
$112,500
$15.1 P/Share
|
Oct 29
2020
|
Uma Sinha Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.77%
|
$360,000
$72.25 P/Share
|
Oct 27
2020
|
Uma Sinha Chief Scientific Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.98%
|
-
|
Oct 08
2020
|
Franco Valle Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
5,199
-100.0%
|
$384,726
$74.85 P/Share
|
Oct 08
2020
|
Franco Valle Senior Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
5,199
+50.0%
|
$36,393
$7.24 P/Share
|
Oct 07
2020
|
Franco Valle Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
5,444
-100.0%
|
$408,300
$75.08 P/Share
|
Oct 07
2020
|
Franco Valle Senior Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+47.87%
|
$35,000
$7.24 P/Share
|
Oct 01
2020
|
Uma Sinha Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,831
-1.46%
|
$251,212
$52.35 P/Share
|